168 related articles for article (PubMed ID: 37288708)
1. NFX1-123: A potential therapeutic target in cervical cancer.
Chintala S; Dankoski MA; Anbarasu A; Ramaiah S; Miryala SK; Katzenellenbogen RA
J Med Virol; 2023 Jun; 95(6):e28856. PubMed ID: 37288708
[TBL] [Abstract][Full Text] [Related]
2. NFX1-123 is highly expressed in cervical cancer and increases growth and telomerase activity in HPV 16E6 expressing cells.
Vliet-Gregg PA; Robinson KL; Levan J; Matsumoto LR; Katzenellenbogen RA
Cancer Lett; 2019 May; 449():106-113. PubMed ID: 30776478
[TBL] [Abstract][Full Text] [Related]
3. High expression of NFX1-123 in HPV positive head and neck squamous cell carcinomas.
Chintala S; Quist KM; Gonzalez-DeWhitt PA; Katzenellenbogen RA
Head Neck; 2022 Jan; 44(1):177-188. PubMed ID: 34693597
[TBL] [Abstract][Full Text] [Related]
4. Cytoplasmic poly(A) binding proteins regulate telomerase activity and cell growth in human papillomavirus type 16 E6-expressing keratinocytes.
Katzenellenbogen RA; Vliet-Gregg P; Xu M; Galloway DA
J Virol; 2010 Dec; 84(24):12934-44. PubMed ID: 20943973
[TBL] [Abstract][Full Text] [Related]
5. Genes Regulated by HPV 16 E6 and High Expression of NFX1-123 in Cervical Cancers.
Chintala S; Levan J; Robinson K; Quist K; Katzenellenbogen RA
Onco Targets Ther; 2020; 13():6143-6156. PubMed ID: 32617009
[TBL] [Abstract][Full Text] [Related]
6. Human Papillomavirus 16 Oncoprotein Expression Is Controlled by the Cellular Splicing Factor SRSF2 (SC35).
McFarlane M; MacDonald AI; Stevenson A; Graham SV
J Virol; 2015 May; 89(10):5276-87. PubMed ID: 25717103
[TBL] [Abstract][Full Text] [Related]
7. Human papillomavirus type 16 E6 and NFX1-123 mislocalize immune signaling proteins and downregulate immune gene expression in keratinocytes.
Levan J; Vliet-Gregg PA; Robinson KL; Katzenellenbogen RA
PLoS One; 2017; 12(11):e0187514. PubMed ID: 29117186
[TBL] [Abstract][Full Text] [Related]
8. HPV type 16 E6 and NFX1-123 augment JNK signaling to mediate keratinocyte differentiation and L1 expression.
Levan J; Vliet-Gregg PA; Robinson KL; Matsumoto LR; Katzenellenbogen RA
Virology; 2019 May; 531():171-182. PubMed ID: 30903928
[TBL] [Abstract][Full Text] [Related]
9. NFX1-123 and human papillomavirus 16E6 increase Notch expression in keratinocytes.
Vliet-Gregg PA; Hamilton JR; Katzenellenbogen RA
J Virol; 2013 Dec; 87(24):13741-50. PubMed ID: 24109236
[TBL] [Abstract][Full Text] [Related]
10. NFX1-123 and poly(A) binding proteins synergistically augment activation of telomerase in human papillomavirus type 16 E6-expressing cells.
Katzenellenbogen RA; Egelkrout EM; Vliet-Gregg P; Gewin LC; Gafken PR; Galloway DA
J Virol; 2007 Apr; 81(8):3786-96. PubMed ID: 17267499
[TBL] [Abstract][Full Text] [Related]
11. Long non-coding RNA FAM83H-AS1 is regulated by human papillomavirus 16 E6 independently of p53 in cervical cancer cells.
Barr JA; Hayes KE; Brownmiller T; Harold AD; Jagannathan R; Lockman PR; Khan S; Martinez I
Sci Rep; 2019 Mar; 9(1):3662. PubMed ID: 30842470
[TBL] [Abstract][Full Text] [Related]
12. Identification of a novel telomerase repressor that interacts with the human papillomavirus type-16 E6/E6-AP complex.
Gewin L; Myers H; Kiyono T; Galloway DA
Genes Dev; 2004 Sep; 18(18):2269-82. PubMed ID: 15371341
[TBL] [Abstract][Full Text] [Related]
13. NFX1-123 increases hTERT expression and telomerase activity posttranscriptionally in human papillomavirus type 16 E6 keratinocytes.
Katzenellenbogen RA; Vliet-Gregg P; Xu M; Galloway DA
J Virol; 2009 Jul; 83(13):6446-56. PubMed ID: 19369336
[TBL] [Abstract][Full Text] [Related]
14. Post-Transcriptional Gene Regulation by HPV 16E6 and Its Host Protein Partners.
Billingsley CL; Chintala S; Katzenellenbogen RA
Viruses; 2022 Jul; 14(7):. PubMed ID: 35891463
[TBL] [Abstract][Full Text] [Related]
15. Inactivation of the human papillomavirus E6 or E7 gene in cervical carcinoma cells by using a bacterial CRISPR/Cas RNA-guided endonuclease.
Kennedy EM; Kornepati AV; Goldstein M; Bogerd HP; Poling BC; Whisnant AW; Kastan MB; Cullen BR
J Virol; 2014 Oct; 88(20):11965-72. PubMed ID: 25100830
[TBL] [Abstract][Full Text] [Related]
16. Development of DNA Vaccine Targeting E6 and E7 Proteins of Human Papillomavirus 16 (HPV16) and HPV18 for Immunotherapy in Combination with Recombinant Vaccinia Boost and PD-1 Antibody.
Peng S; Ferrall L; Gaillard S; Wang C; Chi WY; Huang CH; Roden RBS; Wu TC; Chang YN; Hung CF
mBio; 2021 Jan; 12(1):. PubMed ID: 33468698
[TBL] [Abstract][Full Text] [Related]
17. Human papillomavirus E6 protein enriches the CD55(+) population in cervical cancer cells, promoting radioresistance and cancer aggressiveness.
Leung TH; Tang HW; Siu MK; Chan DW; Chan KK; Cheung AN; Ngan HY
J Pathol; 2018 Feb; 244(2):151-163. PubMed ID: 28944962
[TBL] [Abstract][Full Text] [Related]
18. A novel MLL5 isoform that is essential to activate E6 and E7 transcription in HPV16/18-associated cervical cancers.
Yew CW; Lee P; Chan WK; Lim VK; Tay SK; Tan TM; Deng LW
Cancer Res; 2011 Nov; 71(21):6696-707. PubMed ID: 21908553
[TBL] [Abstract][Full Text] [Related]
19. NFX1 plays a role in human papillomavirus type 16 E6 activation of NFkappaB activity.
Xu M; Katzenellenbogen RA; Grandori C; Galloway DA
J Virol; 2010 Nov; 84(21):11461-9. PubMed ID: 20739528
[TBL] [Abstract][Full Text] [Related]
20. Gene expression profiles are altered in human papillomavirus-16 E6 D25E-expressing cell lines.
Jang M; Rhee JE; Jang DH; Kim SS
Virol J; 2011 Sep; 8():453. PubMed ID: 21943319
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
